Document is current
Any future updates will be listed below
-
Authors
Su, Xue-e
Hong, Wan-ping
He, He-fan
Xie, Baoyuan
Wu, Shan-hu
-
Funding
Funding for this research was provided by:
Joint funds for the innovation of science and technology, Fujian province (2023Y9244)
the Fujian Provincial Clinical Key Specialty Construction Project (HLZDZK202307)
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 10 June 2025
First Online: 18 June 2025
Declarations
:
: This single-blinded, randomized controlled trial was approved by the appropriate ethics committee (2021230) and was registered with the China Clinical Trials Registration Platform (ChiCTR2300069696). The trial followed the uniform standard guidelines for trial reporting, and the procedures were conducted in accordance with the ethical standards of the Declaration of Helsinki. All patients provided informed consent for their participation in the study.
: The authors confirm that all individuals involved in the study have provided their consent for publication of the data and any identifying information included in this manuscript.
: The authors declare no competing interests.
